» Articles » PMID: 30157792

Re-evaluation of the Stroke Prognostication Using Age and NIH Stroke Scale Index (SPAN-100 Index) in IVT Patients - The-SPAN 100 Index

Overview
Journal BMC Neurol
Publisher Biomed Central
Specialty Neurology
Date 2018 Aug 31
PMID 30157792
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The SPAN-100 index adds patient age and baseline NIHSS-score and was introduced to predict clinical outcome after acute ischemic stroke (AIS). Even with high NIHSS-scores younger patients cannot reach a SPAN-100-positive status (index ≥100). We aimed to evaluate the SPAN-100 index among a large, contemporary cohort of i.v.-thrombolysed AIS-patients and exclusively among older patients who can at least theoretically achieve SPAN-100-positivity.

Methods: The SPAN-100 index was applied to AIS-patients receiving i.v.-thrombolysis (IVT) in our institution between 01/2006 and 01/2013. Clinical outcome and symptomatic intracerebral hemorrhage rates were compared between SPAN-100-positive and -negative patients. Furthermore we excluded patients < 65 years, without any theoretical chance to achieve SPAN-100-positivity, and re-evaluated the index (SPAN-100 index).

Results: SPAN-100-positive IVT-patients (124/1002) had a 9-fold increased risk for unfavorable outcome compared to SPAN-negative patients (OR 9.39; 95% CI 5.87-15.02; p <  0.001). The odds ratio for mortality was 7.48 (95% CI 4.90-11.43; p <  0.001). No association was found between SPAN-100-positivity and sICH-incidence (OR 0.88; 95% CI 0.31-2.53; p = 0.810). SPAN-100-positivity (124/741) was associated with an 8-fold increased risk for unfavorable outcome (OR 7.6; 95% CI 4.71-12.22; p <  0.001) but not associated with higher sICH-rates (OR 0.86; 95% CI 0.29-2.53; p <  0.001).

Conclusions: Also for patients ≥65 years the SPAN-100 index can be a fast, easy method to predict clinical outcome of IVT-patients in everyday practice. However, it should not be used to determine the risk of sICH after IVT. Based on a SPAN-positive status IVT should not be withheld from AIS-patients merely because of feared sICH-complications.

Citing Articles

Traditional and machine learning models for predicting haemorrhagic transformation in ischaemic stroke: a systematic review and meta-analysis.

Wang Y, Zhang Z, Zhang Z, Chen X, Liu J, Liu M Syst Rev. 2025; 14(1):46.

PMID: 39987097 PMC: 11846323. DOI: 10.1186/s13643-025-02771-w.


Semantic Visualization in Functional Recovery Prediction of Intravenous Thrombolysis following Acute Ischemic Stroke in Patients by Using Biostatistics: An Exploratory Study.

Hsiao C, Cheng C, Chen C, Chiu H, Lin H, Cheng C J Pers Med. 2023; 13(4).

PMID: 37109009 PMC: 10143597. DOI: 10.3390/jpm13040624.


Age Is Only a Number Also in Hyperacute Stroke Care-But Not an Irrelevant One.

Sipila J J Clin Med. 2022; 11(16).

PMID: 36012975 PMC: 9410087. DOI: 10.3390/jcm11164737.


Nomogram to predict hemorrhagic transformation for acute ischemic stroke in Western China: a retrospective analysis.

Zhang K, Luan J, Li C, Chen M BMC Neurol. 2022; 22(1):156.

PMID: 35468774 PMC: 9040382. DOI: 10.1186/s12883-022-02678-2.


Prediction of Clinical Outcome in Patients with Large-Vessel Acute Ischemic Stroke: Performance of Machine Learning versus SPAN-100.

Jiang B, Zhu G, Xie Y, Heit J, Chen H, Li Y AJNR Am J Neuroradiol. 2021; 42(2):240-246.

PMID: 33414230 PMC: 7872172. DOI: 10.3174/ajnr.A6918.


References
1.
Mishra N, Ahmed N, Andersen G, Egido J, Lindsberg P, Ringleb P . Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ. 2010; 341:c6046. PMC: 2990864. DOI: 10.1136/bmj.c6046. View

2.
Ovbiagele B, Reeves M, Nasiri M, Johnston S, Bath P, Saposnik G . A simple risk index and thrombolytic treatment response in acute ischemic stroke. JAMA Neurol. 2014; 71(7):848-54. DOI: 10.1001/jamaneurol.2014.689. View

3.
Kent D, Selker H, Ruthazer R, Bluhmki E, Hacke W . The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke. 2006; 37(12):2957-62. DOI: 10.1161/01.STR.0000249054.96644.c6. View

4.
. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333(24):1581-7. DOI: 10.1056/NEJM199512143332401. View

5.
Konig I, Ziegler A, Bluhmki E, Hacke W, Bath P, Sacco R . Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke. 2008; 39(6):1821-6. DOI: 10.1161/STROKEAHA.107.505867. View